Trevena
TRVN
#10609
Rank
S$0.01 M
Marketcap
S$0.01555
Share price
0.00%
Change (1 day)
-99.29%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -S$41.19 Million

According to Trevena's latest financial reports the company's current earnings are S$0.54 Million. In 2023 the company made an earning of -S$47.08 Million, an increase over its 2022 earnings that were of -S$67.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$41.19 Million-12.52%
2023 -S$47.08 Million-30.69%
2022 -S$67.93 Million1.38%
2021 -S$67.01 Million78.04%
2020 -S$37.64 Million21.3%
2019 -S$31.03 Million-13.91%
2018 -S$36.04 Million-59.75%
2017 -S$89.53 Million-31.77%
2016 -S$0.14 Billion101.73%
2015 -S$65.05 Million1.14%
2014 -S$64.32 Million114.83%
2013 -S$29.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$10.68 B-26,645.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$0.98 Billion 2,321.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-S$81.38 Million 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.92 B-74,449.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-S$0.82 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-S$13.34 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-S$0.11 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA